We are live on ! Find out more
DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

29 hedge funds and large institutions have $576K invested in Deep Medicine Acquisition Corp. Rights in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more capital invested

Capital invested by funds: $388K → $576K (+$188K)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

3% less funds holding

Funds holding: 30 → 29 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
3
Closed
2
Calls
$351K
Puts
–
Net Calls
+$351K
Net Calls Change
+$18K

Top Buyers

Rank Fund Capital Flow
1
MC
Meteora Capital
Florida
+$3.17K
2
BRF
B. Riley Financial
California
+$1K
3
CAC
Cowen and Company
New York
+$830

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$7.15K
2
KPF
K2 Principal Fund
Ontario, Canada
-$6.85K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1K
4
WAM
Wolverine Asset Management
Illinois
-$57
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
1
Cowen and Company
New York
$132K +$830 +14,517 +0.7%
MP
2
Mangrove Partners
Connecticut
$90K – – –
OCAM
3
Owl Creek Asset Management
New York
$45K – – –
YCM
4
Yakira Capital Management
Connecticut
$45K – – –
SCM
5
Shaolin Capital Management
Florida
$30K – – –
CS
6
Clear Street
New York
$23K – – –
KPF
7
K2 Principal Fund
Ontario, Canada
$21.3K -$6.85K -119,810 -25%
AA
8
AQR Arbitrage
Connecticut
$18.8K – – –
WAM
9
Wolverine Asset Management
Illinois
$15.4K -$57 -1,000 -0.4%
WA
10
Whitebox Advisors
Minnesota
$15K – – –
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$14.8K – – –
SCM
12
Saba Capital Management
New York
$14.7K – – –
Hudson Bay Capital Management
13
Hudson Bay Capital Management
Connecticut
$14.5K -$7.15K -125,000 -30%
Walleye Capital
14
Walleye Capital
New York
$14.5K – – –
PC
15
Periscope Capital
Ontario, Canada
$14.3K – – –
MTCM
16
Mint Tower Capital Management
Netherlands
$12K – – –
CH
17
CVI Holdings
Delaware
$11.5K – – –
PL
18
Parkwood LLC
Ohio
$9K – – –
RCM
19
Rivernorth Capital Management
Florida
$7.5K – – –
SIA
20
SkyView Investment Advisors
New Jersey
$6K – – –
MC
21
Meteora Capital
Florida
$4.84K +$3.17K +55,461 +220%
Walleye Trading
22
Walleye Trading
New York
$4.75K – – –
TCM
23
Tuttle Capital Management
Connecticut
$3.45K – – –
BRF
24
B. Riley Financial
California
$2.86K +$1K +17,500 +58%
FLC
25
Fifth Lane Capital
Texas
$2.5K – – –
1
2

DMAQR Hedge Fund Activity: Q4 2022 in Review

29 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q4 2022, worth a combined $576K — up 48% from $388K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of DMAQR and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.

The largest buyer was Meteora Capital, adding an estimated $3.17K. The largest seller was Hudson Bay Capital Management, cutting an estimated $7.15K.

  • 29 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q4 2022, down from 30 in Q3 2022.
  • Funds reported $576K of Deep Medicine Acquisition Corp. Rights stock for Q4 2022, up 48% quarter-over-quarter.
  • 1 fund opened new Deep Medicine Acquisition Corp. Rights positions in Q4 2022 and 2 closed out, a net change of -1 holder.
  • The largest Deep Medicine Acquisition Corp. Rights buyer in Q4 2022 was Meteora Capital, an estimated $3.17K added.
  • The largest Deep Medicine Acquisition Corp. Rights seller in Q4 2022 was Hudson Bay Capital Management, an estimated $7.15K sold.

Based on aggregated 13F filings for Q4 2022.